NCT00246597 A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer Status TERMINATED Phase PHASE3
NCT00246298 A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients Status TERMINATED Phase PHASE2
NCT00245895 Study of Aranesp to Treat Anemia in Prostate Cancer Patients. Status COMPLETED Phase PHASE2
NCT00239616 Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin Status COMPLETED Phase PHASE2
NCT00239239 Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Status COMPLETED Phase PHASE2
NCT00236977 Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia Status COMPLETED Phase PHASE3
NCT00236964 Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis Status COMPLETED Phase PHASE3
NCT00236951 Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy Status COMPLETED Phase PHASE3
NCT00236938 Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis Status COMPLETED Phase PHASE3
NCT00236678 Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT Status TERMINATED Phase PHASE2
NCT00233597 Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients Status COMPLETED Phase PHASE3
NCT00228995 A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia Status TERMINATED Phase PHASE2
NCT00228436 Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients Status COMPLETED Phase PHASE2
NCT00224068 Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy Status COMPLETED Phase PHASE4
NCT00224003 Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients Status COMPLETED Phase PHASE4
NCT00223964 Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients Status COMPLETED Phase PHASE4